10 Stocks to Buy According to Stephen DuBois’ Camber Capital Management
In this article, we discuss 10 Stocks to Buy According to Stephen DuBois' Camber Capital Management.
Posts Tagged ‘Hedge Fund:499’
Hedge Fund and Insider Trading News: T. Boone Pickens, Carl Icahn, Glen Kacher, Camber Capital Management, Elliott Management, Abbvie Inc. (ABBV), Fidelity National Financial Inc (FNF), and More
In a message he wrote shortly before his death, the legendary oil magnate T.
13G Filing: Camber Capital Management and Tenet Healthcare Corp (THC)
You can access the original SEC filing by clicking here.
13G Filing: Camber Capital Management and AMAG Pharmaceuticals Inc. (AMAG)
You can access the original SEC filing by clicking here.
13G Filing: Camber Capital Management and Amag Pharmaceuticals Inc. (AMAG)
You can access the original SEC filing by clicking here.
13G Filing: Camber Capital Management and Amag Pharmaceuticals Inc. (AMAG)
You can access the original SEC filing by clicking here.
Ptc Therapeutics Inc. (PTCT): Camber Capital Management Adds 500,000 Shares to Its Position
Stephen DuBois' Camber Capital Management recently filed a Form 13G with the SEC, in which it reported raising its stake in Ptc Therapeutics Inc.
Carl Icahn Can’t Stop Buying Cheniere; Nelson Peltz Boosts Stake In SYSCO
Most individual investors already know the value of monitoring activist investors, who generally make value-enhancing proposals or push for changes at struggling companies in ...
Elite Hedge Funds’ Bullish Moves On These Four Stocks
The latest round of 13F filings kicked off at the beginning of October, but as these public filings are only required to be filed within 45 days of the end of each calendar quarter...
Pfizer Inc (PFE) Made Protalix BioTherapeutics, Inc. (PLX) Jump 11% Today
Camber Capital filed an amended 13G on Protalix BioTherapeutics (NYSE:PLX) today disclosing a large increase in its position.
Sequenom, Aclaris, and Xenoport Making Waves Among Elite Healthcare Investors
Three prominent healthcare-focused funds that we track at Insider Monkey submitted filings with the SEC today, disclosing new or bulked up positions in three different healthcare...
Camber Capital Quick To Move On This Newly-Listed Biotech Stock
According to a recent filing with the Securities and Exchange Commission, Stephen DuBois's Camber Capital Management initiated a position in the newly-listed clinical-stage biopharmaceutical...
Healthcare-Focused Fund Camber Capital’s Top Picks: Masimo Corporation (MASI), The Medicines Company (MDCO)
Camber Capital Management is a hedge fund headquartered in Boston and founded by Stephen DuBois.
Epirus Biopharmaceuticals Inc (EPRS): These Two Funds Open New Positions
The days of having no fund activity in Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) are over.
3 Stocks Hedge Funds Just Bought; Should You?
We have a trifecta of recent hedge fund buying activity for you to digest, featuring three different funds and three different stocks.
Masimo Corporation (MASI): Camber Capital Management Ups Passive Position to 5.5%
Stephen DuBois' Camber Capital Management has reported raising its passive position in Masimo Corporation (NASDAQ:MASI).
Universal American Corporation (UAM): Camber Capital Management Resumes Buying Shares
Stephen Dubois’ Camber Capital Management is again increasing its stakes in Universal American Corporation (NYSE:UAM).
Volcano Corporation (VOLC): Camber Capital Takes 9.81% Stake
Stephen Dubois’ Camber Capital Management has disclosed in a regulatory filing with Security and Exchange Commission a stake of 9.81% in medical equipment company Volcano Corporation...
Orthofix International NV (OFIX): Stephen Dubois Surges His Stake Amid Company’s Financial Statements Issues
As a new filing with the Securities and Exchange Commission showed, Camber Capital Management surged its exposure to Orthofix International NV (NASDAQ:OFIX).
Camber Capital Management Adds To Position In Genomic Health, Inc. (GHDX)
Stephen Dubois is optimistic about the prospects of Genomic Health, Inc. (NASDAQ:GHDX) and has increased his fund's holding of the stock.
Camber Capital Surges Stake In Sequenom Inc. (SQNM) To Over 5%
Camber Capital Management, managed by Stephen Dubois, is bullish on Sequenom Inc. (NASDAQ:SQNM).
Camber Capital Management Reveals New Position in Cardica, Inc. (CRDC)
Stephen Dubois' Camber Capital Management revealed a new stake in Cardica, Inc. (NASDAQ:CRDC).
Hedge Fund News: John Paulson, Ray Dalio & Paul Singer
The European unit of US hedge fund firm Paulson & Co, which is run by billionaire investor John Paulson, posted improved profits in the year to the end of March, marking a recovery...
Camber Capital Raises Exposure to CONMED Corporation (CNMD)
Stephen DuBois' Camber Capital has raised its holding in CONMED Corporation (NASDAQ:CNMD).
Stephen DuBois’s Hedge Fund Now Owns a Large Position in Ariad Pharmaceuticals
Stephen DuBois, Ariad Pharmaceuticals: In a new filing just reported to the SEC, Stephen DuBois's Camber Capital disclosed a new 5.4% stake in Ariad Pharmaceuticals, Inc. (...
Camber Capital Takes Big Position in Med-Tech Company Biolase
Camber Capital Management, a hedge fund managed by Stephen Dubois recently disclosed adding a new position to its equity portfolio, BIOLASE Inc (NASDAQ:BIOL).
Hedge Funds Are Selling Humana Inc (HUM)
Humana Inc (NYSE:HUM) has made any of its supporters look smart for some time now. But nothing lasts forever.
